Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.36B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.04B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$951M |
| 4 |
Airbnb
ABNB
|
+$942M |
| 5 |
Kenvue
KVUE
|
+$704M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.7B |
| 2 |
Uber
UBER
|
+$901M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$855M |
| 4 |
Illumina
ILMN
|
+$674M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$637M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.54% |
| 2 | Healthcare | 10.41% |
| 3 | Financials | 10.2% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Fresenius Medical Care
FMS
$13.7B
| $22.4M | ﹤0.01% |
1,041,447
+36,820
| +4% | +$894K |
|
|
CMAX
2327
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $22.4M | ﹤0.01% |
352,644
-49
| -0% | -$3.43K |
|
2328
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$438M
| $22.4M | ﹤0.01% |
298,497
-19,265
| -6% | -$1.52M |
|
2329
InMode
INMD
$881M
| $22.3M | ﹤0.01% |
732,906
+19,068
| +3% | +$749K |
|
2330
iShares MSCI Switzerland ETF
EWL
$2.19B
| $22.3M | ﹤0.01% |
512,148
-50,925
| -9% | -$2.34M |
|
2331
Hancock Whitney
HWC
$6.26B
| $22.3M | ﹤0.01% |
602,216
-41,543
| -6% | -$1.7M |
|
2332
CVR Energy
CVI
$3.31B
| $22.3M | ﹤0.01% |
654,247
+308,277
| +89% | +$10.5M |
|
|
AKRO
2333
DELISTED
Akero Therapeutics
AKRO
| $22.2M | ﹤0.01% |
439,736
+54,078
| +14% | +$2.52M |
|
2334
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.88B
| $22.2M | ﹤0.01% |
288,137
-3,043
| -1% | -$250K |
|
2335
Revolution Medicines
RVMD
$38.9B
| $22.2M | ﹤0.01% |
801,973
-181,522
| -18% | -$5.38M |
|
|
CHS
2336
DELISTED
Chicos FAS, Inc.
CHS
| $22.2M | ﹤0.01% |
2,967,653
+2,124,230
| +252% | +$11.4M |
|
|
SLCA
2337
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $22.1M | ﹤0.01% |
1,577,197
+359,964
| +30% | +$4.7M |
|
2338
Pilgrim's Pride
PPC
$6.63B
| $22.1M | ﹤0.01% |
968,998
+22,834
| +2% | +$556K |
|
|
AMED
2339
DELISTED
Amedisys
AMED
| $22.1M | ﹤0.01% |
236,823
+35,782
| +18% | +$3.31M |
|
2340
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.31B
| $22.1M | ﹤0.01% |
578,335
-45,186
| -7% | -$1.85M |
|
2341
DoubleVerify
DV
$1.78B
| $22.1M | ﹤0.01% |
789,980
-92,597
| -10% | -$3.17M |
|
2342
World Kinect Corp
WKC
$2B
| $22.1M | ﹤0.01% |
984,368
+390,810
| +66% | +$8.71M |
|
2343
Organogenesis Holdings
ORGO
$305M
| $22.1M | ﹤0.01% |
6,940,544
+5,994,373
| +634% | +$19M |
|
2344
BlackRock Core Bond Trust
BHK
$650M
| $22M | ﹤0.01% |
2,216,606
-171,512
| -7% | -$1.79M |
|
|
PCH
2345
DELISTED
PotlatchDeltic
PCH
| $22M | ﹤0.01% |
485,129
+25,083
| +5% | +$1.24M |
|
2346
Goosehead Insurance
GSHD
$2.32B
| $22M | ﹤0.01% |
295,167
-50,232
| -15% | -$3.37M |
|
2347
Viper Energy
VNOM
$8.5B
| $22M | ﹤0.01% |
788,228
-200,047
| -20% | -$5.51M |
|
2348
M/I Homes
MHO
$3.77B
| $22M | ﹤0.01% |
261,327
-108,402
| -29% | -$10M |
|
2349
Itaú Unibanco
ITUB
$93.2B
| $21.9M | ﹤0.01% |
4,629,057
-3,117,667
| -40% | -$15.5M |
|
|
NBIS
2350
Nebius Group N.V.
NBIS
$55.4B
| $21.9M | ﹤0.01% |
1,469,884
-82,911
| -5% | -$1.24M |
|
Similar funds
Morgan Stanley's Q3 2023 Portfolio in Review
As of Q3 2023, Morgan Stanley held 7,879 positions worth $983B, down 3.1% from $1.01T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Morgan Stanley's Q3 2023 filing shows 220 new, 3,248 increased, 3,222 reduced and 253 closed positions. Its largest new stake was TKO Group: 3,583,743 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.7B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2023 buy was TKO Group: 3,583,743 shares worth $301M.
- Morgan Stanley added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $2.36B increase.
- Morgan Stanley's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.7B.
- Morgan Stanley fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $432M.
- Morgan Stanley's ten largest holdings make up 18% of its $983B portfolio in Q3 2023.
- Morgan Stanley opened 220 new positions and closed 253 in Q3 2023.
- Morgan Stanley's portfolio value fell 3.1% quarter-over-quarter to $983B.
Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.